Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers

Dr. Mark Agulnik, MD

Accepting New Patients

(10 Ratings)

Specializes in: Medical Oncology and Adult Oncology

Professional interests include: leukemia, lymphoma, lung cancer, and more.

125 W. Huntington Drive Building A - Suite A200 Building A - Suite A200
Arcadia, CA 91007

(626) 574-2800

Dr. Mark Agulnik, MD is a medical oncologist in Duarte, CA specializing in medical oncology and adult oncology. Dr. Mark Agulnik, MD is affiliated with Keck Medical Center of USC and CITY OF HOPE MEDICAL FOUNDATION.

Office Locations

Address:

1500 E DUARTE ROAD
Duarte, CA 91010

Address:

125 W. Huntington Drive Building A - Suite A200 Building A - Suite A200
Arcadia, CA 91007

Some issues Dr. Mark Agulnik, MD can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

In The News

“said Mark Agulnik, an oncologist at Northwestern University's Robert H. Lurie Comprehensive Cancer Center in Chicago.”—"Gwynn's death renews calls to ban chewing tobacco | HeraldNet.com", Herald Net, June 2014

biological response modifier (BRM) therapy	394
blood draw	195
chemotherapy	394
doctor visit	324
hormone therapy	22
hospital care	68
inpatient care	68
lab tests	761
minimally invasive procedures	413

**Gender**
Male	265
Female	254

**Ethnicity**
Non-Hispanic White	357
Black	97
Hispanic	32
Asian	17
Other	16
Native American	0

**Age**
From 65 to 74	227
From 75 to 84	153
85 and over	39
Less than 65	100

Hypertension	64
High Cholesterol	42
Stroke	7
Ischemic Heart Disease	30
Depression	23
Chronic Kidney Disease	38
Asthma	6
Osteoperosis	11
Atrial Fibrilation	11
Heart Failure	19
Chronic Obstructive Pulmonary Disease	16
Diabetes	25
Dementia	7
Cancer	31

biological response modifier (BRM) therapy	334
blood draw	198
chemotherapy	334
doctor visit	463
hospital care	140
inpatient care	140
lab tests	689
minimally invasive procedures	353

**Gender**
Male	282
Female	224

**Ethnicity**
Non-Hispanic White	356
Black	88
Hispanic	35
Asian	15
Other	12
Native American	0

**Age**
From 65 to 74	254
From 75 to 84	134
85 and over	35
Less than 65	83

Hypertension	61
High Cholesterol	42
Stroke	4
Ischemic Heart Disease	32
Depression	21
Chronic Kidney Disease	42
Asthma	5
Osteoperosis	9
Atrial Fibrilation	9
Heart Failure	21
Chronic Obstructive Pulmonary Disease	15
Diabetes	25
Dementia	4
Cancer	35

biological response modifier (BRM) therapy	388
blood draw	185
chemotherapy	388
doctor visit	447
lab tests	700
minimally invasive procedures	423

**Gender**
Male	536
Female	424

**Ethnicity**
Non-Hispanic White	696
Black	152
Hispanic	52
Asian	34
Other	0
Native American	0

**Age**
From 65 to 74	488
From 75 to 84	254
85 and over	64
Less than 65	154

Hypertension	60
High Cholesterol	46
Stroke	6
Ischemic Heart Disease	34
Depression	24
Chronic Kidney Disease	37
Asthma	11
Osteoperosis	9
Atrial Fibrilation	11
Heart Failure	18
Chronic Obstructive Pulmonary Disease	13
Diabetes	26
Dementia	6
Cancer	35

biological response modifier (BRM) therapy	176
blood draw	185
chemotherapy	176
doctor visit	497
hospital care	70
inpatient care	70
lab tests	711
minimally invasive procedures	210

**Gender**
Male	221
Female	207

**Ethnicity**
Non-Hispanic White	294
Black	83
Hispanic	23
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	218
From 75 to 84	116
85 and over	28
Less than 65	66

Hypertension	66
High Cholesterol	45
Stroke	7
Ischemic Heart Disease	37
Depression	20
Chronic Kidney Disease	41
Asthma	18
Osteoperosis	9
Atrial Fibrilation	10
Heart Failure	21
Chronic Obstructive Pulmonary Disease	17
Diabetes	27
Dementia	9
Cancer	33

biological response modifier (BRM) therapy	400
blood draw	245
chemotherapy	400
doctor visit	758
hormone therapy	14
hospital care	48
inpatient care	48
lab tests	1078
minimally invasive procedures	451

**Gender**
Male	302
Female	244

**Ethnicity**
Non-Hispanic White	390
Black	83
Hispanic	36
Asian	18
Other	0
Native American	0

**Age**
From 65 to 74	314
From 75 to 84	132
85 and over	26
Less than 65	74

Hypertension	66
High Cholesterol	39
Stroke	7
Ischemic Heart Disease	38
Depression	21
Chronic Kidney Disease	42
Asthma	6
Osteoperosis	8
Atrial Fibrilation	10
Heart Failure	19
Chronic Obstructive Pulmonary Disease	14
Diabetes	28
Dementia	8
Cancer	30

biological response modifier (BRM) therapy	384
chemotherapy	384
doctor visit	675
hormone therapy	20
hospital care	59
inpatient care	59
lab tests	184
minimally invasive procedures	449

**Gender**
Male	289
Female	269

**Ethnicity**
Non-Hispanic White	377
Black	91
Hispanic	51
Asian	0
Other	22
Native American	0

**Age**
From 65 to 74	280
From 75 to 84	155
85 and over	35
Less than 65	88

Hypertension	65
High Cholesterol	47
Stroke	4
Ischemic Heart Disease	39
Depression	20
Chronic Kidney Disease	43
Asthma	6
Osteoperosis	8
Atrial Fibrilation	9
Heart Failure	20
Chronic Obstructive Pulmonary Disease	13
Diabetes	27
Dementia	7
Cancer	34

biological response modifier (BRM) therapy	412
chemotherapy	412
doctor visit	631
hormone therapy	27
hospital care	137
inpatient care	137
minimally invasive procedures	483
preventive care	13
vaccines	13

**Gender**
Male	352
Female	268

**Ethnicity**
Non-Hispanic White	422
Black	92
Hispanic	51
Asian	23
Other	32
Native American	0

**Age**
From 65 to 74	326
From 75 to 84	172
85 and over	32
Less than 65	90

Hypertension	67
High Cholesterol	50
Stroke	5
Ischemic Heart Disease	39
Depression	23
Chronic Kidney Disease	43
Asthma	6
Osteoperosis	11
Atrial Fibrilation	11
Heart Failure	21
Chronic Obstructive Pulmonary Disease	14
Diabetes	27
Dementia	8
Cancer	30

biological response modifier (BRM) therapy	136
chemotherapy	136
doctor visit	153
hospital care	74
inpatient care	74
minimally invasive procedures	176

**Gender**
Male	191
Female	143

**Ethnicity**
Non-Hispanic White	235
Black	43
Hispanic	22
Asian	0
Other	18
Native American	0

**Age**
From 65 to 74	167
From 75 to 84	98
85 and over	22
Less than 65	47

Hypertension	63
High Cholesterol	49
Stroke	4
Ischemic Heart Disease	37
Depression	23
Chronic Kidney Disease	44
Asthma	5
Osteoperosis	12
Atrial Fibrilation	14
Heart Failure	24
Chronic Obstructive Pulmonary Disease	13
Diabetes	30
Dementia	10
Cancer	31

doctor visit	907
hospital care	53
inpatient care	53

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

The highest averages for the top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in Duarte, CA were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

biological response modifier (BRM) therapy	328
blood draw	201
chemotherapy	328
doctor visit	540
hormone therapy	20
hospital care	81
inpatient care	81
lab tests	689
minimally invasive procedures	370
preventive care	13
vaccines	13

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Female	203
Male	243

**Ethnicity**
Black / African American	72
Asian / Pacific Islander	10
Non-Hispanic White	312
Native American / Alaskan Native	0
Hispanic	30
Other	10

**Age**
85 and over	28
75 to 84	121
Less than 65	70
65 to 74	227

Average of Total of Conditions of Medicare patients treated by Dr. Mark Agulnik, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Mark Agulnik, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	51
High Cholesterol	36
Stroke	4
Ischemic Heart Disease	28
Depression	17
Chronic Kidney Disease	33
Asthma	6
Osteoporosis	7
Heart Failure	16
Chronic Obstructive Pulmonary Disease	11
Diabetes	21
Atrial Fibrillation	8
Dementia	5
Cancer	25

Education & Training

He completed residency at Mount Sinai Hospital, Chicago. He has a state license in Illinois.

Residency: Mount Sinai Hospital, Chicago

Licensed In: Illinois

Affiliations & Hospitals

Dr. Mark Agulnik, MD is associated with these hospitals and organizations:

Keck Medical Center of USC

CITY OF HOPE MEDICAL FOUNDATION

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Mark Agulnik, MD appears to accept the following insurance providers: Humana ChoiceCare Network, Great-West Healthcare, Blue Shield of California, MultiPlan, TriWest, United Healthcare, Interplan, Aetna, Medicare, Coventry, Cigna, GEHA, Anthem, First Health, Private Healthcare Systems (PHCS), Beech Street, PacifiCare, Health Net, Brand New Day, Marian Health Services, Watchtower, Health Net Covered California, Kern Health Systems, Laundry and Dry Cleaning Workers Health & Welfare, USC Network, Take Care (GUAM), Union Roofers Health & Welfare Fund, Blue Shield Covered California, Presbyterian Intercommunity Hospital, NEXT and Health Plans of Nevada.

Insurance Accepted by Provider includes:

According to our sources, Dr. Mark Agulnik, MD accepts the following insurance providers:

Humana ChoiceCare Network

Great-West Healthcare

Blue Shield of California

MultiPlan

TriWest

United Healthcare

Interplan

Aetna

Medicare

Coventry

Cigna

GEHA

Anthem

First Health

Private Healthcare Systems (PHCS)

Beech Street

PacifiCare

Health Net

Brand New Day

Marian Health Services

Watchtower

Health Net Covered California

Kern Health Systems

Laundry and Dry Cleaning Workers Health & Welfare

USC Network

Take Care (GUAM)

Union Roofers Health & Welfare Fund

Blue Shield Covered California

Presbyterian Intercommunity Hospital

Health Plans of Nevada

Show More

Ratings & Reviews

Dr. Mark Agulnik, MD has an exceptional overall rating with an average of 5.0 out of 5 stars based on 10 ratings. We collect ratings and reviews of Dr. Mark Agulnik, MD from all over the web to help you find the right in Duarte, CA.

Overall Rating

(10 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Mark Agulnik, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Bayer HealthCare Pharmaceuticals Inc.	$99,069 Vitrakvi $83,862	Stivarga $6,665	Nexavar $2,864	Non-Covered $2,560	Aliqopa $12	Other $3,106
Novartis Pharmaceuticals Corporation	$75,466 VOTRIENT - SARCOMA $24,653	NON BRAND $20,771	VOTRIENT $19,012	Gleevec $3,277	AFINITOR $702	Other $7,051
Janssen Scientific Affairs, LLC	$64,993 YONDELIS $46,099	ZYTIGA $18,893
GlaxoSmithKline, LLC.	$48,234 VOTRIENT ARCC $22,657	VOTRIENT $21,376	$4,201
Eli Lilly and Company	$46,780 CYRAMZA $67	$46,713
Other	$194,736 LIBTAYO $33,874	QINLOCK $27,207	OPDIVO $18,025	FYARRO $11,213	Halaven $10,607	Other $93,810

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$279,760
Consulting Fee	$149,748
Travel and Lodging	$42,063
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program	$26,790
Honoraria	$18,300
Other	$12,617

Research Payments

Dr. Mark Agulnik, MD has received 227 research payments totaling $15,873,841.

Biography

Dr. Mark Agulnik is an adult oncology and medical oncology specialist in Duarte, CA, Los Angeles, CA, and Arcadia, CA. These areas are among his clinical interests: leukemia, throat cancer, and lung cancer. Doctor.com reports that Dr. Agulnik is accepting new patients at his office in Duarte, CA.